Advertisement

Ads Placeholder
Loading...

Insmed Incorporated

INSM•NASDAQ
Healthcare
Biotechnology
$162.43
$-2.43(-1.47%)
U.S. Market opens in 27h 44m

Insmed Incorporated (INSM) Stock Overview

Explore Insmed Incorporated’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap35B
P/E Ratio-27.18
EPS (TTM)$-6.41
ROE-1.68%
Fundamental Analysis

AI Price Forecasts

1 Month$138.61
3 Months$181.18
1 Year Target$227.84

INSM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Insmed Incorporated (INSM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 62.13, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $227.84.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -27.18 and a market capitalization of 35B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.47%
5-Day Change
9.76%
1-Month Change
10.50%
3-Month Change
-8.29%
6-Month Change
3.35%
Year-to-Date (YTD) Change
-8.29%
1-Year Change
121.51%
3-Year Change
835.12%
5-Year Change
358.97%
All-Time (Max) Change
-1.56%

Contact Information

https://www.insmed.com
908 977 9900
700 US Highway 202/206, Bridgewater, NJ, 08807

Company Facts

12,710 Employees
IPO DateJun 1, 2000
CountryUS
Actively Trading

Frequently Asked Questions